Back to results
CompletedPhase 1

Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer

NCT00364754

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Pharmina

Tbilisi, Georgia

+9 additional locations

View on ClinicalTrials.gov